Oxybutynin
Product Images NDC 50090-5352

7 FDA label images from A-s Medication Solutions · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Oxybutynin (NDC 50090-5352). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

F8631e88 7755 4b29 848c 7ef657463803 01

F8631e88 7755 4b29 848c 7ef657463803 01
Chemical structure of oxybutynin hydrochloride shown in a molecular diagram format with labeled carbon, oxygen, nitrogen atoms and functional groups.*
FDA Label Image

F8631e88 7755 4b29 848c 7ef657463803 02

F8631e88 7755 4b29 848c 7ef657463803 02
A line graph comparing mean plasma R-oxybutynin concentration (ng/mL) over 24 hours after administration of Oxybutynin Chloride extended-release tablets 10 mg once daily versus oxybutynin 5 mg three times daily. The x-axis represents time in hours (0 to 24), and the y-axis shows concentration levels, with error bars indicating variability.*
FDA Label Image

F8631e88 7755 4b29 848c 7ef657463803 03

F8631e88 7755 4b29 848c 7ef657463803 03
A line graph depicting the mean R-oxybutynin plasma concentration (ng/mL) over time in hours. The concentration peaks around 5 hours and then gradually declines, with data points showing variability indicated by error bars. The time range extends from 0 to 24 hours.*
FDA Label Image

F8631e88 7755 4b29 848c 7ef657463803 04

F8631e88 7755 4b29 848c 7ef657463803 04
A horizontal error bar chart comparing oxybutynin chloride extended-release tablets and placebo. The x-axis ranges from -40 to 40, with data points and error bars shown for both oxybutynin and placebo groups, indicating variation or confidence intervals around the measurements.*
FDA Label Image

F8631e88 7755 4b29 848c 7ef657463803 05

F8631e88 7755 4b29 848c 7ef657463803 05
A horizontal error bar chart comparing oxybutynin chloride extended-release tablets and oxybutynin. The x-axis ranges from -40 to 40, with error bars around the data points for each label positioned near -20 to 0.*
FDA Label Image

F8631e88 7755 4b29 848c 7ef657463803 06

F8631e88 7755 4b29 848c 7ef657463803 06
A chart comparing data related to oxybutynin chloride extended-release tablets and oxybutynin. The horizontal axis appears to range from -40 to 40, with both terms represented along the vertical axis, indicating a comparison of a variable with error bars or ranges.*
FDA Label Image

Label Image (Lbl500905352)

Label Image (Lbl500905352)
Label for oxybutynin chloride 5 mg extended-release tablets by A-S Medication Solutions. The label states a package size of 90 tablets with specific storage instructions to keep between 68 to 77 degrees Fahrenheit, protected from moisture and humidity. The label includes the NDC number 50090-5352-0 and directions to see the package insert.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.